These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9539771)

  • 1. Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade.
    Purbhoo MA; Sewell AK; Klenerman P; Goulder PJ; Hilyard KL; Bell JI; Jakobsen BK; Phillips RE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4527-32. PubMed ID: 9539771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
    Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
    J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Klenerman P; Rowland-Jones S; McAdam S; Edwards J; Daenke S; Lalloo D; Köppe B; Rosenberg W; Boyd D; Edwards A
    Nature; 1994 Jun; 369(6479):403-7. PubMed ID: 7515165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK; Harcourt GC; Goulder PJ; Price DA; Phillips RE
    Eur J Immunol; 1997 Sep; 27(9):2323-9. PubMed ID: 9341776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
    Buseyne F; McChesney M; Porrot F; Kovarik S; Guy B; Rivière Y
    J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
    Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA
    J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.
    Zhao X; Sankaran S; Yap J; Too CT; Ho ZZ; Dolton G; Legut M; Ren EC; Sewell AK; Bertoletti A; MacAry PA; Brzostek J; Gascoigne NRJ
    Nat Commun; 2018 Jul; 9(1):2716. PubMed ID: 30006605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
    Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD
    J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
    J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.
    Tsomides TJ; Aldovini A; Johnson RP; Walker BD; Young RA; Eisen HN
    J Exp Med; 1994 Oct; 180(4):1283-93. PubMed ID: 7523570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.
    Reid SW; McAdam S; Smith KJ; Klenerman P; O'Callaghan CA; Harlos K; Jakobsen BK; McMichael AJ; Bell JI; Stuart DI; Jones EY
    J Exp Med; 1996 Dec; 184(6):2279-86. PubMed ID: 8976183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
    Klenerman P; Meier UC; Phillips RE; McMichael AJ
    Eur J Immunol; 1995 Jul; 25(7):1927-31. PubMed ID: 7542596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.